Fosigotifator
Unknown / undisclosed
Evidence outlook · registrational
Topline reported 2025-01-06
No completed mid-stage readout is on record. The sponsor reported topline results on 2025-01-06 (HEALEY ALS Platform Trial Regimen F (NCT05740813) Phase 2/3 missed its primary endpoint). The announcement is listed under Regulatory events.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. The complete registry, including every study not featured here, is listed below.
| Trial | Phase | Endpoint | Key result | Signal | Source |
|---|---|---|---|---|---|
NCT04948645 NCT04948645 · ALS, Amyotrophic Lateral Sclerosis Although this trial was randomized and blinded, it was terminated early and no results have been posted, so it does not provide a completed, usable comparison of fosigotifator against placebo. Registry: NCT04948645 | 1 | Safety and Tolerability (Baseline Up to Approximately Day 28); Pharmacokinetics (Baseline Up to Approximately Day 28); Pharmacokinetics (Baseline Up to Approximately Day 28) 2025-07-15 | Results not posted; external-source review pending | Weak signal | link ↗ |
All registered studies
Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.
Phase 2/3 (2)
What this study did
What this study did
Phase 1/2 (1)
What this study did
Phase 1 (7)
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
Early phase / not applicable (1)
What this study did
Competitive landscape
No competitors sharing a mechanism or indication in the current universe.
Upcoming events
(4 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Follow Fosigotifator to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.
Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2027 (3)
July 2027 (1)
What to watch
2029 (1)
January 2029 (1)
What to watch
Regulatory and conference events
(1)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent